Isolation of potent neutralizing monoclonal antibodies from an SIV-infected rhesus macaque by phage display

AIDS Research and Human Retroviruses

Volumn 27, Issue 5, 2011, Pages 487-500

  Kuwata, Takeo ^a   Katsumata, Yuko ^a   Takaki, Kaori ^a   Miura, Tomoyuki ^b   Igarashi, Tatsuhiko ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN P27; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY ISOLATION; ANTIBODY RESPONSE; ARTICLE; BIOPANNING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE INSERTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PHAGEMID; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN FAB FRAGMENTS; MACACA MULATTA; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE LIBRARY; SEQUENCE ANALYSIS, DNA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 79955783725     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0191     Document Type: Article

References (52)

1. Igarashi T, Brown C, Azadegan A, et al.: Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat Med 1999;5(2):211-216. (Pubitemid 29068529)
2. Shibata R, Igarashi T, Haigwood N, et al.: Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat Med 1999;5(2):204-210. (Pubitemid 29068528)
3. Veazey RS, Shattock RJ, Pope M, et al.: Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 2003;9(3): 343-346. (Pubitemid 36362791)
4. Hessell AJ, Rakasz EG, Poignard P, et al.: Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog 2009;5(5):e1000433.
5. Mascola JR, Stiegler G, VanCott TC, et al.: Protection of macaques against vaginal transmission of a pathogenic HIV- 1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000;6(2):207-210. (Pubitemid 30082367)
6. D'Souza MP, Livnat D, Bradac JA, and Bridges SH: Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: Performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group. J Infect Dis 1997;175(5):1056-1062. (Pubitemid 27176491)
7. Walker LM, Phogat SK, Chan-Hui PY, et al.: Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 2009;326(5950):285-289.
8. Saphire EO, Parren PW, Pantophlet R, et al.: Crystal structure of a neutralizing human IGG against HIV-1: A template for vaccine design. Science 2001;293(5532):1155-1159. (Pubitemid 32758099)
9. Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, and Wyatt RT: The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 2008;6(2):143-155.
10. Li Y, Migueles SA, Welcher B, et al.: Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 2007;13(9):1032-1034. (Pubitemid 47517505)
11. Haynes BF, Fleming J, St Clair EW, et al.: Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 2005;308(5730):1906-1908. (Pubitemid 40941873)
12. Ofek G, McKee K, Yang Y, et al.: Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region. J Virol 2010;84(6):2955-2962.
13. Poignard P, Saphire EO, Parren PW, and Burton DR: gp120: Biologic aspects of structural features. Annu Rev Immunol 2001;19:253-274. (Pubitemid 32368036)
14. Hirsch VM and Lifson JD: Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. Adv Pharmacol 2000;49:437-477.
15. Hirsch V, Adger-Johnson D, Campbell B, et al.: A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J Virol 1997;71(2):1608-1620. (Pubitemid 27030338)
16. Johnson WE, Sanford H, Schwall L, et al.: Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J Virol 2003; 77(18):9993-10003. (Pubitemid 37122081)
17. Means RE, Matthews T, Hoxie JA, Malim MH, Kodama T, and Desrosiers RC: Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: Correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4. J Virol 2001;75(8):3903-3915. (Pubitemid 32246399)
18. Samuelsson A, Chiodi F, Ohman P, Putkonen P, Norrby E, and Persson MA: Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus. Virology 1995; 207(2):495-502.
19. Chassagne S, Laffly E, Drouet E, Herodin F, Lefranc MP, and Thullier P: A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library. Mol Immunol 2004;41(5):539-546. (Pubitemid 38750199)
20. Glamann J, Burton DR, Parren PW, et al.: Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: Recovery from a longterm- nonprogressor SIV-infected macaque. J Virol 1998; 72(1):585-592. (Pubitemid 28048875)
21. Druar C, Saini SS, Cossitt MA, et al.: Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein. Immunogenetics 2005;57(10):730-738. (Pubitemid 41598619)
22. Cole KS, Alvarez M, Elliott DH, et al.: Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology 10 2001;290(1):59-73. (Pubitemid 33111876)
23. Robinson JE, Cole KS, Elliott DH, et al.: Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. AIDS Res Hum Retroviruses 1998;14(14): 1253-1262. (Pubitemid 28488936)
24. Lusso P, Cocchi F, Balotta C, et al.: Growth of macrophagetropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): Failure to downregulate CD4 and to interfere with cell-linetropic HIV-1. J Virol 1995;69(6):3712-3720.
25. Takeuchi Y, McClure MO, and Pizzato M: Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J Virol 2008;82(24):12585-12588.
26. Wei X, Decker JM, Liu H, et al.: Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002;46(6):1896-1905. (Pubitemid 34535213)
27. Derdeyn CA, Decker JM, Sfakianos JN, et al.: Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 2000;74(18):8358-8367. (Pubitemid 30666686)
28. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, and Kabat D: Effects of CCR5 and CD4cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 1998;72(4):2855-2864. (Pubitemid 28175522)
29. Morner A, Bjorndal A, Albert J, et al.: Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 1999;73(3):2343-2349. (Pubitemid 29098139)
30. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, and Calos MP: Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987;7(1): 379-387. (Pubitemid 17230421)
31. Kuwata T, Byrum R, Whitted S, et al.: A rapid progressorspecific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses. J Virol 2007;81(17):8891-8904. (Pubitemid 47311434)
32. Kuwata T, Dehghani H, Brown CR, et al.: Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: Evidence of differential selection of RP-specific envelope mutations in vitro and in vivo. J Virol 2006;80(3):1463-1475. (Pubitemid 43134103)
33. Kuwata T, Nishimura Y, Whitted S, et al.: Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies. PLoS Pathog 2009;5(4): e1000372.
34. Kestler H, Kodama T, Ringler D, et al.: Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 1990;248(4959):1109-1112.
35. Mori K, Ringler DJ, Kodama T, and Desrosiers RC: Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol 1992;66(4):2067-2075.
36. Shibata R, Miura T, Hayami M, et al.: Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). J Virol 1990;64(2):742-747. (Pubitemid 20032690)
37. Barbas CF, Scott JM, Silverman G, and Burton DR: Phage Display: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2001.
38. Robinson JE, Holton D, Liu J, McMurdo H, Murciano A, and Gohd R: A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin A. J Immunol Methods 1990;132(1):63-71. (Pubitemid 20263863)
39. Kent KA, Gritz L, Stallard G, et al.: Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS 1991;5(7):829-836.
40. Kent KA, Rud E, Corcoran T, et al.: Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res Hum Retroviruses 1992;8(6):1147-1151.
41. Lefranc MP, Giudicelli V, Ginestoux C, et al.: IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 2009;37(Database issue):D1006-1012.
42. Ourmanov I, Kuwata T, Goeken R, et al.: Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody. J Virol 2009;83(11):5388-5400.
43. Andris JS, Miller AB, Abraham SR, et al.: Variable region gene segment utilization in rhesus monkey hybridomas producing human red blood cell-specific antibodies: Predominance of the VH4 family but not VH4-21 (V4-34). Mol Immunol 1997;34(3):237-253. (Pubitemid 27293739)
44. Bible JM, Howard W, Robbins H, and Dunn-Walters DK: IGHV1, IGHV5 and IGHV7 subgroup genes in the rhesus macaque. Immunogenetics 2003;54(12):867-873. (Pubitemid 36470081)
45. Ermert K, Mitlohner H, Schempp W, and Zachau HG: The immunoglobulin kappa locus of primates. Genomics 1995; 25(3):623-629.
46. Helmuth EF, Letvin NL, and Margolin DH: Germline repertoire of the immunoglobulin V(H)3 family in rhesus monkeys. Immunogenetics 2000;51(7):519-527. (Pubitemid 30394459)
47. Howard WA, Bible JM, Finlay-Dijsselbloem E, Openshaw S, and Dunn-Walters DK: Immunoglobulin light-chain genes in the rhesus macaque I: Kappa light-chain germline sequences for subgroups IGKV1, IGKV and IGKV3. Immunogenetics 2005;57(3-4):210-218. (Pubitemid 40775578)
48. Howard WA, Bible JM, Finlay-Dijsselbloem E, Openshaw S, and Dunn-Walters DK: Immunoglobulin light-chain genes in the rhesus macaque II: Lambda light-chain germline sequences for subgroups IGLV1, IGLV2, IGLV3, IGLV4 and IGLV5. Immunogenetics 2005;57(9): 655-664. (Pubitemid 41457487)
49. Link JM, Hellinger MA, and Schroeder HW Jr: The rhesus monkey immunoglobulin IGHD and IGHJ germline repertoire. Immunogenetics 2002;54(4):240-250. (Pubitemid 34824134)
50. Link JM, Larson JE, and Schroeder HW: Despite extensive similarity in germline DH and JH sequence, the adult rhesus macaque CDR-H3 repertoire differs from human. Mol Immunol 2005;42(8):943-955. (Pubitemid 40489020)
51. Scinicariello F, Engleman CN, Jayashankar L, McClure HM, and Attanasio R: Rhesus macaque antibody molecules: Sequences and heterogeneity of alpha and gamma constant regions. Immunology 2004;111(1):66-74. (Pubitemid 38091051)
52. Gibbs RA, Rogers J, Katze MG, et al.: Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007;316(5822):222-234. (Pubitemid 46633091)